News
Resources
Blog
Sites
Mark Keida Mark Keida, Ph.D. is a Deputy Vice President in Public Affairs. He leads PhRMA’s message and polling team, supporting advocacy communications, paid media campaigns and earned media. Mark specializes in using data to guide narrative, campaign strategy and tactics.
Recent Posts
4 Things to know about PhRMA’s new 50-state poll
By Mark Keida | May 4, 2023
When it comes to health care, Americans are concerned about innovation and affordability.
Read More
Navigating the patient experience: Burdens and barriers standing between patients and their care
By Mark Keida | September 12, 2022
Health care affordability is not the only hurdle facing patients, according to PhRMA’s third Patient Experience Survey (PES). The latest PES report exposes another crucial problem: the frustration...
Read More
New survey: Voters seriously concerned about fine print in reconciliation bill
By Mark Keida | August 12, 2022
With a final vote in Congress expected on a reconciliation spending bill, a new Morning Consult survey explores what this legislation actually does – and does not do – and finds that voters are...
Read More
The patient experience: Insurance design hurdles lead to access issues for too many Americans, including communities of color and the chronically ill.
By Mark Keida | October 28, 2021
3 in 10 insured Americans still face a financial barrier to care and some of the most vulnerable patients are also those more likely to experience barriers in accessing their care, according to our...
Read More
Data shows voters strongly support protecting access to their medicines
By Mark Keida | July 15, 2021
In our current health care system, the Medicare Part D program helps ensure seniors and people with disabilities have access to the prescription medicines they need. While more than 90% of seniors...
Read More
Data shows that Americans are relying on vaccines to get us through the pandemic
By Mark Keida | April 22, 2021
As we continue to combat the pandemic, America’s biopharmaceutical industry is working around the clock in unprecedented partnerships to manufacture COVID-19 vaccines, reaching billions of doses by...
Read More
Data shows that keeping a strong biopharmaceutical industry is important to Americans
By Mark Keida | March 30, 2021
The United States biopharmaceutical industry continues to innovate and discover critical solutions for our toughest health challenges such as the COVID-19 pandemic. America’s global leadership has...
Read More
Top five issues voters want addressed in the administration’s first 100 days
By Mark Keida | February 18, 2021
When voters cast their ballots in the 2020 election, they made clear their focus on getting COVID-19 under control and fixing the economy. However, health care was still important to many voters, and...
Read More
Growing trend: Increased vaccine confidence
By Mark Keida | January 28, 2021
According to researchers writing in The Lancet, we need a majority of Americans to have the confidence to get vaccinated for COVID-19 if we are going to be effective in moving the United States...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
